HCA Healthcare, Inc. (HCA) Earnings Call Transcripts

HCA Healthcare, Inc.'s Latest Earnings Call - Q2 FY2026

In the second quarter of 2026, HCA Healthcare reported revenues of $19.5 billion, reflecting a year-over-year increase but falling short of expectations due to a significant decline in patients covered by health insurance exchanges. The company experienced diluted earnings per share growth of 11%, maintaining its guidance for the fiscal year with revenue expectations adjusted to between $77 billion and $79.5 billion. Management highlighted a concerning shift in payer mix, with a 15% decline in exchange patients contributing to increased uninsured volumes, which could impact future profitability.

Reported metrics

Guidance from management

HCA maintained its revenue guidance for the year between $77 billion and $79.5 billion, while adjusting its EBITDA guidance to reflect a long-term growth target of 4% to 6%. The company expects continued pressure from the payer mix shift but remains optimistic about demand growth.

What management said

Thank you, Mike. As a reminder, please limit yourself to one question so we might give as many as possible in the queue an opportunity to ask a question. Abby, you may now give instructions to those who would like to ask a question.

Yes. I don't have a different explanation for the second quarter versus the year-to-date. I think it's hard sometimes in short cycles to make judgments about demand, and 90 days is a short cycle. So I think from that standpoint, I don't think the explanation varies much from quarter-to-quarter. And so a midyear review, I think, is a more relevant perspective on that. So I don't really have anything to add additionall...

What analysts pressed on

Analysts expressed concerns regarding the significant decline in exchange patients and the impact on future profitability. There were also questions about the sustainability of the current volume growth and the potential for further declines in elective surgeries as economic pressures persist.

Main topics on the call

• Payer Mix Shift — HCA experienced a significant unfavorable shift in payer mix, with a 15% decline in adjusted admissions from patients previously covered by health insurance exchanges. CEO Sam Hazen noted, 'These patients migrated almost...
• Volume Growth — Despite the payer mix challenges, HCA reported solid volume growth in insured patients, with emergency room visits up 3.6% and overall admissions increasing by 2.5%. Management expressed optimism about long-term demand g...
• Capital Expenditures — HCA announced over $7 billion in capital expenditures planned over the next three years to enhance capacity and service offerings. This investment aims to improve competitive positioning and meet anticipated demand growt...
• Adjusted EBITDA Guidance — The company revised its adjusted EBITDA guidance to a range of $15.4 billion to $16.1 billion, reflecting a long-term growth rate target of 4% to 6%. Management indicated that the updated guidance accounts for the increa...

Read the full HCA Healthcare, Inc. transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 86 HCA Healthcare, Inc. earnings call transcripts on record, spanning January 28, 2020 to July 24, 2026. Based on this history, HCA Healthcare, Inc. reports quarterly. The most recent call on file is dated July 24, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

HCA

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

86

First call

January 28, 2020

Most recent

July 24, 2026

Reporting cadence

quarterly